Brief: Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference
04/12/2025 14:05
Dec 4 (Reuters) - Edwards Lifesciences Corp EW.N: EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCE REAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10% : REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62 PROJECTS 2026 SALES GROWTH OF 8%-10% OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95 FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION -- LSEG IBES DATA FY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION -- LSEG IBES DATA Source text: ID:nBw4HJSQNa Further company coverage: EW.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals